Motley Fool Staff
the_motley_fool
Recent Articles by Motley Fool Staff

Jan 10, 2017
by Motley Fool Staff
Biotech Resolutions: More Innovation, Better Execution, and Fewer Price Hikes
It's time for biopharma to double down on growing sales and profits through research and development, rather than via drug price increases. And, while we're at it, improving execution on late-stage drug candidates ought to be front and center this year, too.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.